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Introduction: The aim of this retrospective study was to evaluate the ability of intraoperative neuro-
monitoring to predict the postoperative functional outcome and its role in reducing the postoperative
recurrent laryngeal nerve palsy rate during thyroidectomy for thyroid malignancy.
Methods: Between June 2007 and March 2013, 656 consecutive patients with thyroid cancer underwent
thyroidectomy by a single surgical team. We compared 357 patients who have had neuromonitoring
(Group A) to 299 patients who have undergone surgery with nerve visualization alone (group B).
Results: In group A 7 recurrent laryngeal nerve paralysis were observed (1.96%), 6 (1.68%) transient and 1
(0.28%) permanent; a bilateral recurrent laryngeal palsy was observed in 1 of the 7 cases (0.28%). In
group B 6 recurrent laryngeal nerve paralysis were observed (2.01%), 5 (2.01%) transient and 1 perma-
nent (0.33%); bilateral palsy was observed in 1 of the 6 cases (0.33%). Differences were not statistically
signiﬁcative.
Conclusions: Routine visual nerve identiﬁcation remains the gold standard of recurrent laryngeal nerve
management in surgery for thyroid cancer. Intraoperative neuromonitoring is safe, effective, reliable, and
easy to perform in excluding postoperative recurrent laryngeal palsy. It helps to identify the nerve in
thyroid cancer, but it did not decrease the injuries compared with visualization alone in this study;
however, its use can change the operative strategy in order to prevent the risk of bilateral damage in case
of signal loss. Future studies are needed to evaluate the beneﬁt of intraoperative neuromonitoring in
thyroidectomy for thyroid cancer.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Recurrent laryngeal nerve (RLN) palsy is one of the most com-
mon and dreaded complication after thyroid surgery [1e4].
In 1938 Lahey ﬁrst proposed routine identiﬁcation of the RLN
during thyroid surgery which has been demonstrated to decrease
the incidence of postoperative nerve palsy [1,4e9]. Since then,
many prospective studies have conﬁrmed this observation, advo-
cating routine nerve identiﬁcation as the “gold standard” in safe
thyroid surgery [1,4,10,11]. Nevertheless, RLN palsy still remains a
common and feared complications of thyroid surgery [12]. The
incidence of nerve injury is reported to range between 0 and even
more than 20%; the risk is higher for thyroid cancer, Graves' disease,by Elsevier Ltd. All rights reservedre-operation, mediastinal goiter, surgeon’s low experience and in
case of failure of RLN identiﬁcation [1,4,12e21]. Voice impairment
affects the quality of life and represents the most frequent reason
for litigation in endocrine surgery [1e4,6,9,12,22,23].
In recent years, intraoperative neuromonitoring (IONM) has
been proposed to reduce the risk of RLN injury [1,5,24]. RLN
monitoring is being used with increasing frequency in the United
States and in Europe, particularly in Germany [11,17,25e28]. How-
ever, the reduction of frequency in RLN injury and the value of
predicting postoperative nerve function remain controversial
[1,4,6]; the use of RLNmonitoring is associated with increased time
of setup and increased cost of equipment by about 5e7% [27,28].
The economic impact of the procedure is considerable, owing to the
costs of the technology, which, for the entire equipment set-up,
could vary from 15,000 to 20,000 Euro [29,30].
The aim of this retrospective study was to evaluate the ability of
this technique to predict the postoperative functional outcome and.
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during thyroidectomy for thyroid malignancy.2. Methods
This retrospective study has been conducted to determine the
outcomes of thyroidectomy for primary thyroid cancer performed
with IONM (IONM group, group A) compared to conventional
technique without the use of IONM (control group, group B). In the
control group, the RLN was routinely identiﬁed solely by visual
detection. Preoperative diagnosis has been based on ultrasound-
guided ﬁne-needle aspiration cytology and serum calcitonin
measurement.
Between June 2007 and March 2013, 656 consecutive patients
with thyroid cancer underwent thyroidectomy by a single surgical
team. 476 patients were submitted to total thyroidectomy, 169 to
total thyroidectomy with VI level lymphectomy, and 11 underwent
completion total thyroidectomy. 520 were female and 136 male
with a mean age of 51 years (range 15e87 years).
All operations were performed by three experienced endocrine
surgeons, with a standard Kocher’s incision. All patients were
submitted to preoperative and postoperative laryngoscopy.
The study was approved by the Bioethics Committee of the
University of Cagliari. All patients provided written informed con-
sent for the intervention and for the storage and use of their data.
The recurrent laryngeal nerves were routinely identiﬁed by
visualization and completely exposed.
Intraoperative neuromonitoring was performed in 357 patients
on the basis of the availability of the equipment (714 nerves at risk).
All these patients undergone general anesthesia and were intu-
bated with Nerve Integrity Monitor Standard Reinforced Electro-
miography Endotracheal Tube (Medtronic Xomed). The tube was
placed with the middle of the blue-marked region (3 cm of the
exposed electrodes) well in contact with the true vocal cords under
direct laryngoscopy. When the monitor was well set up, we
routinely checked the impedance of electrodes. A Prass monopolar
stimulation probe (Medtronic Xomed) was used for nerve stimu-
lation during thyroidectomy. EMG activity was recorded on an
NIM-response 2.0 or 3.0 monitor (Medtronic Xomed). No muscle
relaxants were used after the skin ﬂaps were elevated.
The neuromonitoring device was used in various phases of the
operation: at the beginning a stimulation was done to the level
corresponding to the vagus nerve to ensure that the monitoring
system was working; after to the structure believed to be attrib-
utable to the inferior laryngeal nerve; at the end to the level of both
the vagus and the recurrent nerve after the removal of thyroid and
the complete hemostasis of the surgical ﬁeld and was used for
predicting the postoperative outcome.
Patients in which the nerve monitor did not function properly
were excluded from the study.
We compared patients who have had neuromonitoring and
patients who have undergone surgery with nerve visualization
alone.
Patients in which neuromonitoring was utilized (group A) were
357 (714 nerves at risk). 255 (71.42%) were submitted to a total
thyroidectomy, 4 (1.12%) to a completion total thyroidectomy andTable 1
Surgical procedures in the two groups (Group A: with IONM, Group B: without IONM).
Total n (%) Total thyroidectomy n (%) Comple
Group A 357 (100%) 255 (71.43%) 4 (1.12%
Group B 299 (100%) 221 (73.91%) 7 (2.34%98 (27.45%) to a total thyroidectomy associated to a VI level lym-
phectomy (Table 1).
Patients in which neuromonitoring was not utilized (Group B)
were 299 (598 nerves at risk). 221 (73.91%) were submitted to total
thyroidectomy, 7 (2.34%) to completion total thyroidectomy and 71
(23.74%) to a total thyroidectomy associated to a VI level lym-
phectomy (Table 1).
Groups were well matched for characteristics of patients, diag-
nosis and type of surgery.
We deﬁne “transient” an injury in which the motility of the
vocal cords recovered within 12 months after surgery.
Parameters were tested using the chi-square test. A logistic
regression analysis was ﬁtted using transient and permanent palsy
as measurements of outcome. A p value of less than 0.05 was
considered to be signiﬁcant. Statistical analysis was done with SPSS
software (SPSS in, Chicago, III).
3. Results
The ﬁnal diagnosis was differentiated carcinoma in 626 patients
(95.4%) (512 papillary and 114 follicular), and medullary carcinoma
in 30 (4.6%).
Lymph node metastasis were found in 50 patients (7.62%) and
micrometastasis in 14 (2.13%). Totally lymph node metastasis were
observed in 64 patients (9.75%).
Complete follow-up was available for all patients. No mortality
was observed.
In group A 7 recurrent laryngeal nerve paralysis were observed
(1.96%), 6 (1.68%) transient and 1 (0.28%) permanent. A bilateral
recurrent laryngeal palsy was observed in 1 of the 7 cases (0.28%).
In group B 6 recurrent laryngeal nerve paralysis were observed
(2.01%) of which 5 (2.01%) transient and 1 permanent (0.33%).
Bilateral palsy was observed in 1 of the 6 cases (0.33%) (Table 2).
Differences between the two groups were not statistically
signiﬁcative.
The median postoperative hospital stay was 2 days in both
groups.
In group A we had 6 true positive cases, 348 true negative, 2
false positive and 1 false negative. Accuracy of neuromonitoring
was 99.1%, positive predictive value 75%, negative predictive value
99.7%. Sensitivity was 85.7% and speciﬁcity 99.4% (Table 3).
Recurrent laryngeal nerve paralysis in the two groups in relation
to type of surgery are reported in Table 2. Differences were not
statistically signiﬁcant.
No complications were attributable to the use of intraoperative
neuromonitoring.4. Discussion
In 1938 Lahey ﬁrst dissected the recurrent laryngeal nerve in
virtually every case; visual identiﬁcation of RLN during thyroid
operations has been associated with lower rates of permanent
recurrent laryngeal nerve palsy and is considered the gold standard
of RLN treatment by many studies [31e33]. Meticulous surgery,
experience, and specialization have steadily reduced temporary
and permanent inferior laryngeal nerve paralysis in thyroid surgery




Recurrent laryngeal nerve paralysis in the two groups in relation to type of surgery (Group A: with IONM, Group B: without IONM).
Group A (357 patients) n (%) Group B (299 patients) n (%) p value
Recurrent Nerve Palsy 7 (1.96%) 6 (2.01%) 0.8109 p > 0.05
 Unilateral 6 (1.68%) 5 (1.67%) 0.7665 p > 0.05
 Bilateral 1 (0.28%) 1 (0.33%) 0.5583 p > 0.05
Transient Nerve Palsy 6 (1.68%) 5 (1.67%) 0.7665 p > 0.05
 Total Thyroidectomy 4/255 (1.57%) 4/221 (1.81%) 0.8782 p > 0.05
 Completion thyroidectomy 1/4 (25%) 1/7 (14.29%) 0.7118 p > 0.05
 Total thyroidectomy þ lymphectomy 1/98 (1.02%) 0/71 (0%) 0.871 p > 0.05
Permanent Nerve Palsy 1 (0.28%) 1 (0.33%) 0.5583 p > 0.05
 Total Thyroidectomy 1/255 (0.39%) 0/221 (0%) 0.9428 p > 0.05
 Completion thyroidectomy 0/4 (0%) 0/7 (0%)
 Total thyroidectomy þ lymphectomy 0/98 (0%) 1/71 (1.41%) 0.871 p > 0.05
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patients undergoing re-operation or operations for thyroid cancer,
hyperthyroidism, sub-sternal goiters, thyroiditis, in cases of previ-
ous radiotherapy, or in presence of anatomic variants
[15,33,35e42].
The use of IONM in thyroid surgery has gained increasing
acceptance because of several advantages, and it has recently been
well standardized [43,44]. In the United States, approximately 40%,
and in Germany, almost 90% of thyroid surgery procedures are
estimated to be monitored in this manner [38]. Nevertheless, its
impact in the avoidance of nerve injury and the reduction of the
incidence of postoperative nerve palsy remain doubtful [30,44,45].
Several non-randomised studies demonstrated that an
improved intraoperative RLN identiﬁcation rate with IONM resul-
ted in lower palsy rates than in historical patient cohorts with
identiﬁcation alone [20,23]. A large non-randomized multicenter
trial conducted in Germany with more than 16,000 patients re-
ported that the device could help in decreasing the risk of nerve
injury [20,23,32], while a multicentre study of 4382 patients found
a statistically signiﬁcant reduction in rates of transient and per-
manent RLN paralysis with the use of IONM in surgery for benign
goiter [13,23,30].
On the other side, a large single-centre study of 1000 consecu-
tive nerve at risk found that continuous nerve monitoring offered
absolutely no beneﬁt in reducing the risk of nerve injury compared
with the adoption of routine nerve identiﬁcation, with no differ-
ence in both the temporary and the permanent nerve injury rates
[30,45].
In the study of Dralle [4] IONM did not lower the risk of nerve
injury although failure to visually identify the nerve was associated
with a higher rate of injury; nerve injury rates were also higher for
low-volume hospitals and low-volume surgeons and this fact was
conﬁrmed by others [1,28,33,45].
In the meta-analysis by Higgins [22] and in the recent meta-
analysis by Pisanu [44], IONM and identiﬁcation alone did not
demonstrate a statistically signiﬁcant difference in rates of total,
transient, or persistent true vocal fold palsy.Table 3







Positive predictive value 75%
Negative predictive value 99.7%
Sensitivity 85.7%
Speciﬁcity 99.4%Other studies claim that IONM is really of value only in high-risk
surgery, re-operative cases, or recurrent goiters [28,30], but an
impractically large number of patients would be needed because of
the rarity of nerve injury that is achieved in specialized centers
[44].
In a prospective, randomized study of 1000 patients (1000
nerves at risk for each group), the prevalence of transient RLN palsy
was 2.9% lower in high-risk patients who had surgery with IONM as
surgery for cancer including central lymph node dissection,
thyrotoxicosis, retrosternal or giant goiter, and thyroiditis patients
[1,46]; the study of Frattini [15] conﬁrmed the effectiveness of
IONM in high-risk thyroid procedures such as cancer patients.
In the study of Barczynski [43] the use of IONM allowed for
decreasing the risk of RLN injury by 3.7%, including a 3% drop in the
risk of transient and a 0.7% drop in the risk of permanent damage.
The improvement of these outcomes was accompanied by a sig-
niﬁcant increase of radicality of thyroid tissue resection in the
group operated on with IONM as assessed by postoperative 131I
uptake and the percentage of patient with iodine uptake below 1%
increased when IONM was employed by as much as 45% [43].
In our study the rate of postoperative recurrent laryngeal nerve
paralysis in patients operated on for thyroid cancer did not differ
signiﬁcantly from visual nerve identiﬁcation alone. The rate of
transient and deﬁnitive recurrent laryngeal nerve paralysis were
1.68% and 0.28% respectively in group A (with IONM) and 1.67% and
0.33% in group B (visualization alone). The main weakness of this
and other studies on this topic is the inadequate power to identify a
statistical difference and this is a signiﬁcant limitation. The patients
were not randomized which could lead to bias, but the number of
patients is large and the groups are well matched. Our opinion is
that IONM can help in nerve identiﬁcation particularly in difﬁcult
situation such as reoperative surgery, surgery for cancer with
lymph node dissection, or anatomic variations but it is very hard to
demonstrate a statistically signiﬁcant reduction in the incidence of
RLN damages because an extremely large number of patients would
be needed. However a critical point remains the fact that difﬁcult
situations are not always predictable preoperatively.
Regarding the occurrence of vocal cord palsy, the outcome is
excellent for patients with an intact monitoring signal at the end of
the operation, which is consistent with the high negative predictive
value of the procedure (97e99%), but it is extremely unpredictable
when there is a loss of signal at the end of a thyroidectomy because
of the low positive predictive value (PPV) of the procedure
(33e37.8%). This means that two-thirds of nerves with a missing
monitoring signal can expect normal vocal cord function after
surgery [28,44]. This failure may be due to technical pitfalls,
problems with the technical device, wrong application or contin-
uous relaxation during the operation with paralysed vocal
musculature [23,44].
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(85.7%) and speciﬁcity (99.4%) of this method; positive predictive
value was 75% and negative predictive value 99.7% which is similar
to other data reported in the literature.
The use of these devices in thyroid surgery seems to be more
expensive than the conventional technique. This is probably the
major disadvantage [33] and particularly for this reason routine
nerve monitoring is no cost-effective [30].
The proponents of routine nerve monitoring claim that its use
can still be justiﬁed for bilateral surgery stating that contralateral
lobe resectionmust be avoided after loss of signal in the ﬁrst lobe to
avoid the risk of bilateral damage and tracheostomy
[1,6,23,30,41,44]. This is in fact a particularly dreaded complication
for its dramatic consequences [47]. The reconsideration of surgical
strategy after a missing signal in one site must be evaluated, mainly
for reoperative surgery in patients at major risk of bilateral RLN
palsy [44,48]. Following this recommendation, however, two-third
of patients might require unnecessary two-stage thyroidectomy
[44].
IONM provides comfort during thyroidectomy for dissection,
identiﬁcation, and control of RLNs; it can reduce the stress of the
surgeon associated with nerve dissection in cases of a challenging
anatomy or extensive surgery [9,36] but the main beneﬁt remains
its ability to guide the surgeon in situations where the anatomic
situation diverges from normality [36,42]. However the use of
IONM in only selected cases does not allow adequate familiarity
with the device and can lead to pitfalls.
In our experience, the use of this technique has decreased the
stress of the surgeon, facilitated the identiﬁcation of the nerve and
given greater safety in the prosecution of the most difﬁcult oper-
ations. These effects, however, are very hard to quantify. RLN
paresis occurrence diminishes the quality of life for a few weeks to
months after thyroid surgery; so any improvement in this ﬁeld is
welcome [1]. RLN monitoring also allows for nerve function
documentation before and after thyroid resection (by printing the
electromyographic signal of evoked potentials), which is of great
importance in case of litigation [1,36].
In conclusion, routine visual nerve identiﬁcation remains the
gold standard of RLN management in surgery for thyroid cancer.
The technique of IONM is safe, effective, reliable, and easy to
perform in excluding postoperative RLN palsy. IONM helps to
identify the RLN, in particular in difﬁcult cases, but it did not
decrease RLN injuries compared with visualization alone in this
study; however, the use of IONM can change the operative strategy
in order to prevent the risk of bilateral damage in case of signal loss.
Future studies are needed to evaluate the beneﬁt of IONM in thy-
roidectomy for thyroid cancer.
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